Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Proteasome activates OTUD7B. 1 / 1

| 1

➶

reach

"It was reported that Lys11 modified APC/C substrates are targeted for proteasomal degradation XREF_BIBR, XREF_BIBR, but surprisingly, inhibition of the proteasome by MG132 or epoxomicin, which efficiently stabilised HIF-1alpha protein levels, did not rescue the effect of Cezanne knockdown on HIF-1alpha (Fig XREF_FIG B, Supplementary Fig S4A and C)."

25355043

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...